Quantum BioPharma Ltd.
QNTMNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $15.10M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.07$15.00
- Volume (live)
- -
- Avg. volume (3M)
- 182.87K
Quantum BioPharma (QNTM) Stock Price & Financial Analysis
Quantum BioPharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.25 - $2.43 |
|---|---|
| 52-Week High | $15.00 |
| 52-Week Low | $2.07 |
| Open | $2.37 |
| Volume (last close) | 150.36K |
| Average Volume (3M) | 182.87K |
| 50-Day MA | $3.31 |
|---|---|
| 200-Day MA | $4.07 |
| 1-Year Change | −84.28% |
| Market Cap | 15.10M |
|---|---|
| Shares Outstanding | 6.65M |
| Price to Book (P/B) | 2.48 |
| EV/EBITDA | -0.51 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Quantum BioPharma at a Glance
As of the Oct 22, 2026 close, Quantum BioPharma (QNTM) has a market capitalization of $15.10M.
As of its latest reported balance sheet, it holds $3.65M in cash and securities against $898.39K of debt, a net cash position of $2.75M.
Quantum BioPharma does not currently pay a dividend.
The share price is down 84.3% over the past year. At $2.27 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $2.07 to $14.99, below its 200-day moving average of $4.07.
Frequently Asked Questions About Quantum BioPharma
What is the current stock price for QNTM?
As of the Oct 22, 2026 close, QNTM stock trades at $2.27. The 52-week range is $2.07–$15.00, with a day range of $2.25–$2.43.
What is the P/E ratio for QNTM?
The P/E ratio (Price-to-Earnings) for QNTM is shown in the Key Statistics section. This valuation metric helps compare Quantum BioPharma Ltd. to industry peers.
Does QNTM pay dividends?
Quantum BioPharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for QNTM?
Analyst ratings and recommendations for QNTM are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of QNTM?
As of the Oct 22, 2026 close, Quantum BioPharma's market capitalization is $15.1M, classifying it as a micro-cap company. Quantum BioPharma operates in the Healthcare sector within the Biotechnology industry.